Marquette Asset Management’s Assembly Biosciences ASMB Stock Holding History

Marquette Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,016	Closed	-$142K	–	155
2024 Q4	$142K	Hold	9,016	–	–	0.02%	111
2024 Q3	$137K	Hold	9,016	–	–	0.02%	118
2024 Q2	$124K	Hold	9,016	–	–	0.02%	94
2024 Q1	$120K	Buy	9,016 +4,477	+99%	+$52.2K	0.02%	104
2023 Q4	$44.7K	Buy	+4,539	New	+$43.2K	0.01%	142
2022 Q4	–	Sell	-4,854	Closed	-$96K	–	225
2022 Q3	$96K	Hold	4,854	–	–	0.03%	109
2022 Q2	$122K	Hold	4,854	–	–	0.03%	113
2022 Q1	$120K	Buy	4,854 +854	+21%	+$18.3K	0.03%	131
2021 Q4	$112K	Buy	4,000 +1,697	+74%	+$55.6K	0.02%	140
2021 Q3	$96K	Buy	2,303 +412	+22%	+$17.3K	0.02%	144
2021 Q2	$88K	Buy	+1,891	New	+$93.7K	0.02%	143

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Marquette Asset Management's ASMB Position: Q1 2025 in Review

Marquette Asset Management sold out of Assembly Biosciences (ASMB) in Q1 2025, closing a stake of 9,016 shares — an estimated $142K sold.

Marquette Asset Management first reported a position in ASMB in Q2 2021 and held it in 11 quarters. The position peaked at $142K in Q4 2024. 37 funds tracked by Wall St. Rank hold ASMB as of Q1 2025.

Marquette Asset Management reported no remaining Assembly Biosciences position as of Q1 2025 after selling out during the quarter.
Marquette Asset Management sold 9,016 Assembly Biosciences shares in Q1 2025, an estimated $142K.
Marquette Asset Management first reported a position in Assembly Biosciences in Q2 2021 and held it in 11 quarters.
Marquette Asset Management's Assembly Biosciences position peaked at $142K in Q4 2024.
37 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2025.

Based on Marquette Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.